<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01143233</url>
  </required_header>
  <id_info>
    <org_study_id>Hipp2010</org_study_id>
    <nct_id>NCT01143233</nct_id>
  </id_info>
  <brief_title>Low-protein Infant Formula With Partial or Extensive Proteinhydrolysate 4 Year Follow-up</brief_title>
  <acronym>HippHA</acronym>
  <official_title>Suitability of an Infant Formula With Reduced Protein Content Based on a Partial Respectively an Extensive Proteinhydrolysate With and Without Pro- and Prebiotics for the Particular Nutritional Use by Infants.-Extension by 4 Year Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HiPP GmbH &amp; Co. Vertrieb KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HiPP GmbH &amp; Co. Vertrieb KG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is conducted to examine the suitability of partially respectively extensively
      hydrolyzed low protein infant formulae with and without pro- and prebiotics for healthy, term
      infants.

      Primary hypothesis to be tested is: an infant formula based on a Protein hydrolysate with
      modified protein content is non inferior compared to a standard infant formula based on a
      Protein hyrolysate in respect to proper growth of healthy, term infants within the first four
      month of life.

      4-year follow-up (without further Intervention) will focus on body composition and allergic
      predisposition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      View Section Brief Summary
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>average weight gain</measure>
    <time_frame>4 months</time_frame>
    <description>The intervention is to assess average weight gain in the first 4 months of life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>allergic sensitization and symptoms</measure>
    <time_frame>12 months</time_frame>
    <description>blood sample to assess allergic predisposition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric data at age of 4 years</measure>
    <time_frame>4 years</time_frame>
    <description>Weight, length and Head circumference measurements at Age of 4 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition (Skin fold) at age of 4 years</measure>
    <time_frame>4 years</time_frame>
    <description>Caliper measurement at Age of 4 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition (fat mass, lean body mass) at age of 4 years</measure>
    <time_frame>4 years</time_frame>
    <description>bioelectrical impedance Analysis at Age of 4 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Allergic predisposition at age of 4 years by measuring specific IgE in blood</measure>
    <time_frame>4 years</time_frame>
    <description>blood sample to allergic predisposition at Age of 4 years</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">503</enrollment>
  <condition>Disturbance of Growth</condition>
  <arm_group>
    <arm_group_label>control formula group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>infants are fed a commercial, hydrolysed formula during the first 4 month of life, according to protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention formula 1 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infants are fed hydrolyzed infant formula with different protein content during the first 4 month of life, according to protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention formula 2 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infants are fed hydrolyzed infant formula with different protein content with pro- and prebiotics during the first 4 month of life, according to protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention formula 3 group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infants are fed hydrolyzed instant formula with different protein content with pro- and prebiotics during the first 4 months of life, according to protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reference group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>infants are breast fed</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control formula</intervention_name>
    <description>infants are fed a commercial hydrolyzed formula</description>
    <arm_group_label>control formula group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intervention formula 1</intervention_name>
    <description>formula has hydrolysed protein and a different protein content</description>
    <arm_group_label>intervention formula 1 group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intervention formula 2</intervention_name>
    <description>formula has hydrolysed protein, different protein content and pro- and prebiotics</description>
    <arm_group_label>intervention formula 2 group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intervention formula 3</intervention_name>
    <description>formula has hydrolysed protein, different protein content and pro- and prebiotics</description>
    <arm_group_label>intervention formula 3 group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  written informed consent (by parents, caregiver)

          -  Healthy term newborns (gestational age: ≥ 37 weeks)

          -  Birth weight between 2.500 - 4.500 g

          -  Age at enrolment: &lt; 28 days of age

          -  Infant received no other formula since birth

          -  Parents / Caregivers are able to speak German

        Exclusion Criteria:

          -  Severe acquired or congenital illness

          -  preterm infants (gestational age &lt; 37 weeks)

          -  Birth weight lower than 2.500 g or higher than 4.500 g

          -  Feeding a cows milk based formula or any other formula prior to inclusion in this
             study

          -  Participation in any other clinical study intervention

          -  Regular intake of supplementary pre- and probiotics by the child and/or breastfeeding
             mother

          -  Mothers with diabetes mellitus or mothers suffered from gestational diabetes

          -  Founded assumption that it will not be possible for parents / caregivers to be
             compliant with the study protocol

          -  Breastfed infants: illness of the mother, that may have an influence on the
             gastrointestinal tract of the child

          -  Breastfed infants: mother receives or received antibiotics one week before inclusion
             in this study or during the first study phase
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>27 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich Wahn, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité - Universitätsmedizin. Campus Virchow-Klinikum. Klinik für Pädiatrie mit Schwerpunkt Pneumologie/Immunologie</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kirsten Beyer, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité - Universitätsmedizin. Campus Virchow-Klinikum. Klinik für Pädiatrie mit Schwerpunkt Pneumologie/Immunologie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder- und Jugendheilkunde, Abt. Neonatologie, päd. Intensivmedizin und Neuropädiatrie</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Rostock</name>
      <address>
        <city>Rostock</city>
        <state>Mecklenburg-Vorpommern</state>
        <zip>18059</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Kinder- und Jugendmedizin der Ruhr-Universität Bochum</name>
      <address>
        <city>Bochum</city>
        <state>Nordrhein-Westfalen</state>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin. Campus Virchow-Klinikum. Klinik für Pädiatrie mit Schwerpunkt Pneumologie/Immunologie</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KBC &quot;Dr Dragiša Mišović Dedinje&quot;</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Serbia</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2010</study_first_submitted>
  <study_first_submitted_qc>June 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2010</study_first_posted>
  <last_update_submitted>November 29, 2017</last_update_submitted>
  <last_update_submitted_qc>November 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

